Similarly, the ICC uses a 10% blast cutoff for most molecularly defined subtypes of AML, again with the exception of BCR::ABL1 to avoid confusion with the diagnosis of chronic myeloid leukemia (CML). The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.